Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

Graphene’s latest miracle? The ability to detect cancer cells

Add as a preferred source on Google

This is a great year for graphene researchers, who have identified astonishing new applications for the amazing wonder material seemingly every week.

The latest? The fact that it turns out to be pretty darn good at cancer detection, thereby hinting at the possibility of a future noninvasive tool for early diagnosis.

Recommended Videos

The work was carried out by scientists at the University of Illinois at Chicago, who placed brain cells (astrocytes) taken from mice onto a graphene sheet, comprising a one-atom-thick layer of carbon atoms, and found that the sheet was able to distinguish between a single cancerous cell (glioblastoma or GMB cell) and a normal cell.

“What we’ve shown is that a graphene-based system can detect the activity of a cell, and by doing that we can differentiate between a cancer cell and a normal cell,” Vikas Berry, associate professor and head of chemical engineering at UIC, told Digital Trends. “That’s because a cancer cell is hyperactive and has a different biochemistry on its surface and degree of activity that it exhibits. Based on the activity of the cell, we are able to make our differentiation.”

Image used with permission by copyright holder

The amazing cancer-detecting abilities of graphene relate to its impressive electrical conductivity. When exposed to a hyperactive cancerous cell, the electric field around the cell pushed away electrons in the graphene’s shared electron cloud. This changes the vibration energy of the carbon atoms: something which can be studied using ultra-high resolution vibration energy mapping. As a result, the researchers were able to tell what kind of cell the graphene was interfacing with.

“It’s an incredibly sensitive mechanism for detection,” Berry continued.

It’s exciting stuff, and could have significant real-world impacts. At present, however, it’s still a long way from clinical use. However, the researchers are hoping to expand beyond mouse trials to human patient biopsies in the future. They also hope that the same approach could be used to distinguish between different types of bacteria, and also identify sickle cells.

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more